CollPlant Biotechnologies Ltd
CLGN- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001631487
No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in CollPlant Biotechnologies Ltd as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −3 vs. Q3 2022
- Shares held
- 1.58M
- +6.00K (+0.4%) vs. Q3 2022
- Total value
- $13.1M
- +$2.37M (+22.1%) vs. Q3 2022
- New holders
- 2
- 2 more added
- Sold out
- 5
- 5 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $582.4K |
| Q1 2026 | 21 | $819.0K |
| Q4 2025 | 17 | $1.93M |
| Q3 2025 | 19 | $4.08M |
| Q2 2025 | 18 | $2.53M |
| Q1 2025 | 16 | $3.33M |
| Q4 2024 | 14 | $4.59M |
| Q3 2024 | 13 | $6.79M |
| Q2 2024 | 16 | $7.39M |
| Q1 2024 | 13 | $7.59M |
| Q4 2023 | 17 | $9.14M |
| Q3 2023 | 18 | $8.55M |
| Q2 2023 | 17 | $12.5M |
| Q1 2023 | 18 | $10.9M |
| Q4 2022 | 18 | $13.1M |
| Q3 2022 | 21 | $10.7M |
| Q2 2022 | 20 | $14.3M |
| Q1 2022 | 16 | $19.5M |
| Q4 2021 | 21 | $29.5M |
| Q3 2021 | 15 | $33.1M |
| Q2 2021 | 16 | $51.9M |
| Q1 2021 | 15 | $24.4M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding CollPlant Biotechnologies Ltd; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Roumell Asset Management, LLC | 605,437 | $5.06M | 12.52% | 00.0% | Unchanged |
| Investment Management of Virginia LLC | 463,899 | $3.87M | 0.76% | +60,326+14.9% | Added |
| Villere St Denis J & Co LLC | 287,147 | $2.40M | 0.19% | +950+0.3% | Added |
| Brown Advisory Inc | 73,849 | $616.6K | 0.00% | 00.0% | Unchanged |
| Benjamin F. Edwards & Company, Inc. | 61,050 | $510.0K | 0.02% | −4,360−6.7% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 23,190 | $193.6K | 0.00% | 00.0% | Unchanged |
| Simon Quick Advisors, LLC | 15,676 | $130.9K | 0.02% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 12,639 | $105.5K | 0.00% | −3,743−22.8% | Reduced |
| UBS Group AG | 7,040 | $58.8K | 0.00% | −2,126−23.2% | Reduced |
| Credit Suisse AG | 6,100 | $50.9K | 0.00% | +6,100 | New |
| Bank of America Corp | 4,800 | $40.1K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 3,600 | $30.1K | 0.00% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 750 | $6.26K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 250 | $2.09K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 171 | $1.43K | 0.00% | −2−1.2% | Reduced |
| First Manhattan Co | 100 | $835 | 0.00% | 00.0% | Unchanged |
| Private Advisor Group, LLC | 10,490 | $88 | 0.00% | −2,372−18.4% | Reduced |
| GWM Advisors LLC | 400 | $3 | 0.00% | +400 | New |
| LPL Financial LLC | 0 | $0 | 0.00% | −28,070−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,265−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −5,250−100.0% | Sold out |
| Cohanzick Management, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −585−100.0% | Sold out |